Medilines Distributors Inc. said it will continue to focus on markets with resilient demands as it grows its business.
The company is wrapping up its initial public offering.
“Crafting our product portfolio is at the heart of Medilines’ strategy that has brought us sustainable growth over the years,” said Virgilio Villar, Medilines chairman.
“We focus on products with resilient demand while building our capabilities to dominate certain markets rather than chasing a hot selling item that everybody else is selling,” he added.
Villar said this strategy “provides stability in sales as their products remain critically necessary for patient care regardless of whether the pandemic prolongs.”
Medilines is the largest distributor in the Philippines of cancer therapy equiipment with over 90 percent market share and of dialysis machines with over 50 percent share.
